carbidopa and Coronary Disease

carbidopa has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lehnert, H; Lombardi, F; Lorenzo, AV; Lown, B; Raeder, EA; Verrier, RL; Wurtman, RJ	1

Other Studies

1 other study(ies) available for carbidopa and Coronary Disease

Article	Year
Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat. Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coronary Disease; Female; Heart; Heart Rate; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenelzine; Serotonin; Ventricular Fibrillation	1987

Article

Year

Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.

Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:4

Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coronary Disease; Female; Heart; Heart Rate; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenelzine; Serotonin; Ventricular Fibrillation

1987